Bliss GVS Pharma (BOM:506197) FFO


BOM:506197 Bliss GVS Pharma Ltd BOM:506197
63 GF Score
Price ₹506.15
GF Value ₹151.49
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bliss GVS Pharma FFO?

FFO (Funds from operations) only applies to REITs.

BOM:506197
63GF Score
Bliss GVS Pharma Ltd BOM:506197
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bliss GVS Pharma (BOM:506197) Overvalued in 2026?

Based on GuruFocus' analysis, Bliss GVS Pharma stock appears to be overvalued. The current stock price of ₹506.15 is trading 234.1% above its estimated GF Value™ of ₹151.49. GuruFocus considers Bliss GVS Pharma to be Significantly Overvalued.

Key valuation signals for BOM:506197:

  • FFO:
  • GF Value™: ₹151.49 vs. price of ₹506.15 (234.1% above fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the BOM:506197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bliss GVS Pharma Business Description

Other Exchanges BLISSGVS:India
Address Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.
63GF Score

Get the complete analysis for BOM:506197

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹506.15
Price
₹151.49
GF Value